152 related articles for article (PubMed ID: 24175838)
1. Alteration of runt-related transcription factor 3 gene expression and biologic behavior of esophageal carcinoma TE-1 cells after 5-azacytidine intervention.
Wang S; Liu H; Akhtar J; Chen HX; Wang Z
Asian Pac J Cancer Prev; 2013; 14(9):5427-33. PubMed ID: 24175838
[TBL] [Abstract][Full Text] [Related]
2. Effects of 5-azacytidine on RUNX3 gene expression and the biological behavior of esophageal carcinoma cells.
Wang S; Liu H; Wang Z; Chen HX
Mol Med Rep; 2014 Apr; 9(4):1259-65. PubMed ID: 24535051
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of RUNX3 inhibits malignant behaviour of Eca109 cells in vitro and vivo.
Chen HX; Wang S; Wang Z; Zhang ZP; Shi SS
Asian Pac J Cancer Prev; 2014; 15(4):1531-7. PubMed ID: 24641363
[TBL] [Abstract][Full Text] [Related]
4. Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC).
Chen H; Wang Z; Wang S; Zhang Z; Shi S
Med Oncol; 2015 Jan; 32(1):357. PubMed ID: 25428380
[TBL] [Abstract][Full Text] [Related]
5. Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells.
Moon JW; Lee SK; Lee JO; Kim JH; Kim N; Kim J; Kim HS; Park SH
Anticancer Res; 2014 Jan; 34(1):133-40. PubMed ID: 24403453
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
7. Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma.
Liu ZH; Liu JJ; Li SS; Yang XM
Cancer Invest; 2016; 34(2):105-13. PubMed ID: 26853927
[TBL] [Abstract][Full Text] [Related]
8. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
10. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
11. [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2].
Han X; Tan ZJ; Guo RD; Li ZJ; Wang YL
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):17-21. PubMed ID: 23648294
[TBL] [Abstract][Full Text] [Related]
12. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
[TBL] [Abstract][Full Text] [Related]
13. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
15. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma.
Arai M; Imazeki F; Sakai Y; Mikata R; Tada M; Seki N; Shimada H; Ochiai T; Yokosuka O
Oncol Rep; 2008 Aug; 20(2):405-12. PubMed ID: 18636205
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
18. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
19. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
20. Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro.
Feng XZ; He XS; Zhuang YZ; Luo Q; Jiang JH; Yang S; Tang XF; Liu JL; Chen T
World J Gastroenterol; 2008 May; 14(19):3006-14. PubMed ID: 18494051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
